Milestone reached as HIV remission achieved in second patient
A patient treated with a stem cell transplant has been in remission from HIV for 18 months and is no longer taking HIV drugs.
Read More
Tag: Hodgkin’s lymphoma
SMC nod for Novartis’ Kisqali, MSD’s Keytruda
The Scottish Medicines Consortium (SMC has published new guidelines approving NHS funding for medicines for breast cancer and Hodgkin’s lymphoma.
Read More
NICE bars Adcetris from routine NHS use for Hodgkin’s lymphoma
It is looking likely that patients with Hodgkin’s lymphoma will not be getting access to Takeda’s Adcetris on the National Health Service in England, after the drug was turned down again by cost regulators despite new data and a drop in price.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
